Glucocorticoid receptor is required for skin barrier competence by Bayo, Pilar et al.
 1 
 
Glucocorticoid receptor is required for skin barrier competence  
Short title: Glucocorticoid receptor regulates skin development 
 
Pilar Bayo (1), Ana Sanchis (1), Ana Bravo (2), Jose Luis Cascallana (2), Katrin Buder (3), 
Jan Tuckermann (3,4), Günther Schütz (4) and Paloma Pérez (1,5,*) 
 
 (1) Centro de Investigación Príncipe Felipe CIPF, Av. Autopista del Saler 16, Camino de las 
Moreras, E-46013 Valencia, Spain 
 (2) Department of Veterinary Clinical Sciences, Veterinary Faculty, University of Santiago de 
Compostela, E-27002 Lugo, Spain  
(3) Molecular Biology of Tissue specific Hormone Action, Leibniz Institute for Age Research, 
Fritz Lipmann Institute, Beutenbergstr. 11, D-07745 Jena, Germany 
(4) 
 Dept. Molecular Biology of the Cell I, German Cancer Research Center, D-69120 
Heidelberg, Germany 
(5) Instituto de Biomedicina de Valencia IBV-CSIC, Jaime Roig 11, E-46010 Valencia, Spain 
* Corresponding author: Paloma Pérez. Centro de Investigación Príncipe Felipe (CIPF) and 
Instituto de Biomedicina de Valencia (CSIC) 
Address correspondence: Paloma Pérez, Centro de Investigación Príncipe Felipe, Valencia, Av. 
Autopista del Saler 16, Camino de las Moreras, E-46013-Valencia, Spain. 
Tel +34 96 328 9680 
Fax +34 96 328 9701 
pperez@cipf.es 
 
Keywords: glucocorticoid receptor, DNA-binding function, epidermal homeostasis, cross-talk, 
ERK  
This work was supported by grant SAF2005-00412 from the Spanish Ministerio de Educación y 
Ciencia, by the "Fonds der Chemischen Industrie" and the European Union through grant 
LSHM-CT-2005-018652 (CRESCENDO) and by grant DFG Tu-220/3 from the Deutsche 
Forschungsgemeinschaft. 
Disclosure statement: The authors of this manuscript have nothing to disclose. 
 Endocrinology. First published ahead of print November 26, 2007 as doi:10.1210/en.2007-0814
Copyright (C) 2007 by The Endocrine Society 
 2 
Abstract 
To investigate the contribution of the glucocorticoid receptor (GR) in skin development and the 
mechanisms underlying this function, we have analyzed two mouse models in which GR has 
been functionally inactivated: the knock-out GR-/- mice and the dimerization mutant GRdim/dim 
that mediates defective DNA binding-dependent transcription. Since GR null mice die 
perinatally, we evaluated skin architecture of late embryos by histological, 
immunohistochemical and electron microscopy studies. Loss-of-function of GR resulted in 
incomplete epidermal stratification with dramatically abnormal differentiation of GR-/-, but not 
GR+/- embryos, as demonstrated by the lack of loricrin, filaggrin and involucrin markers. Skin 
sections of GR-/- embryos revealed edematous basal and lower spinous cells and electron 
micrographs showed increased intercellular spaces between keratinocytes and reduced number 
of desmosomes. The absent terminal differentiation in GR-/- embryos correlated with an 
impaired activation of caspase-14, which is required for the processing of profilaggrin into 
filaggrin at late embryo stages. Accordingly, the skin barrier competence was severely 
compromised in GR-/- embryos. Cultured mouse primary keratinocytes (MPK) from GR-/- mice 
formed colonies with cells of heterogeneous size and morphology that showed increased growth 
and apoptosis, indicating that GR regulates these processes in a cell-autonomous manner. The 
activity of ERK1/2 was constitutively augmented in GR-/- skin and MPKs relative to wt, which 
suggests that GR modulates skin homeostasis, at least partially, by antagonizing ERK function. 
Moreover, the epidermis of GR+/dim and GRdim/dim embryos appeared normal, thus suggesting 
that DNA-binding-independent actions of GR are sufficient to mediate epidermal and hair 
follicle development during embryogenesis. 
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Introduction  
In mammals, the epidermis is a stratified 
epithelium that acts as a barrier preserving 
the organism from dehydration, 
uncontrolled thermoregulation and 
potentially environmental damage. The 
acquisition of a competent barrier occurs 
during embryonic development and it 
requires a correct balance between 
proliferation, differentiation and controlled 
apoptosis. To exert this key function, the 
epidermis must be able to self renew under 
both homeostatic and injury conditions by 
maintaining a population of proliferative 
keratinocytes in the basal layer (BL) and 
hair follicles (HF) (reviewed in 1, 2). The 
process of differentiation implies that basal 
keratinocytes cease to proliferate, lose 
adherence to the basement membrane and 
migrate to outer layers called spinous (SL), 
granular (GL) and stratum corneum (SC). 
During mouse skin development and, as 
basal cells move outwards, gene expression 
of basal keratinocytes, such as keratin K5, 
is repressed and switches towards 
differentiation specific markers, including 
keratins K1 and K10. Epidermal terminal 
differentiation is a tightly regulated process 
that ends up in the conversion of viable 
keratinocytes into dead, flattened squames 
of the SC, a process which represents a 
form of programmed cell death (1). In the 
mouse, the first suprabasal layer of the 
epidermis is formed around embryonic 
14.5-15.5 dpc and the number of epidermal 
cell layers increases, with the SC being 
formed at 18.5 dpc. Alterations in the 
processes of keratinocyte proliferation and 
differentiation during fetal development 
may lead to a disturbed epidermal barrier, 
which can cause skin disorders of 
keratinization and cornification (reviewed 
in 3). Recent findings demonstrated that the 
nonapoptotic caspase-14 plays a role in 
epidermal homeostasis since its activation 
at late stages of epidermal development in 
utero is required for terminal keratinocyte 
differentiation, contrary to classical 
caspases involved in apoptosis, such as 
caspase-3 (4, 5). 
Although glucocorticoid (GC) 
analogs are widely prescribed as the 
treatment of choice in many cutaneous 
disorders (6), the role of GCs in skin 
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development has not been completely 
deciphered (3). In some reports, GCs have 
been shown to accelerate epidermal barrier 
formation as seen by either GC injections in 
utero (7) or, conversely, by showing that 
corticotropin-releasing hormone-deficient 
newborn mice, which exhibited GC 
deficiency, had delayed maturation of the 
SC (8); moreover, supplementation of GCs 
in these mice fully rescued skin phenotype 
(8). In experiments performed in adult 
mouse skin, short-term topical and systemic 
GC treatment disturbed epidermal barrier 
competence (9). These results highlight that 
the responses to GCs depend on the stages 
in development (fetal vs. adult) and also 
due to the use of physiological vs 
pharmacological doses of GCs. 
Since GC effects are mediated 
through the glucocorticoid receptor (GR), 
studying the impact of the gain- and loss-
of-function of GR in skin development and 
function through genetically modified mice 
constitutes a relevant issue from the basic 
and clinical perspective. GR acts through 
the so-called genomic and non-genomic 
actions exerting pleiotropic roles in many 
tissues, including skin (reviewed in 10). GR 
belongs to the superfamily of steroid 
nuclear receptors and is a ligand-dependent 
transcription factor. In the absence of 
ligand, GR resides in the cytoplasm 
asociated with chaperones such as Hsp90, 
in an inactive form. Upon ligand binding, 
GR dissociates from cytoplasmic 
complexes, dimerizes and translocates to 
the nucleus, where it can then regulate gene 
transcription by binding to positive and 
negative glucocorticoid response elements 
(GREs). GR can regulate gene expression 
through DNA-binding-dependent and -
independent mechanisms. The former 
requires ligand-induced dimerization of GR 
and binding to specific GREs, whereas the 
latter does not require DNA-binding of GR, 
but rather is mediated through interference 
with other transcription factors, such as NF-
κB or AP-1 (11). Non-genomic actions of 
GR have been demonstrated and are 
mediated through physical interaction of the 
receptor at the plasma membrane with 
p85α/PI3K which, in turn, modulates AKT 
activity (12). 
To decipher the role of GR in skin 
development, we have evaluated the skin 
architecture of two mouse models in which 
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GR has been functionally inactivated: the 
knock-out GR-/- mice (13, 14) and the 
knock-in mice carrying the point mutation 
A458 in the D-loop of GR, which impairs 
dimerization-induced DNA-binding of the 
GR, thus resulting in a mutant protein that 
display defective DNA binding-dependent 
transcription (GRdim/dim, 15). GR-/- mice die 
perinatally whereas GRdim/dim animals are 
viable. Altogether, our analyses 
demonstrate that GR is required for proper 
epidermal differentiation, which is in part 
mediated by caspase-14 processing during 
mouse embryogenesis. In addition, GR 
regulated keratinocyte growth and 
apoptosis in a cell-autonomous manner, as 
shown by the observed increased 
proliferation and cell death in cultured 
mouse primary keratinocytes (MPKs) from 
GR-/- mice. GR controlled skin homeostasis, 
at least partially, through antagonistic 
modulation of ERK function both in vivo 
and in vitro. Moreover, and given that the 
epidermis of GRdim/dim embryos appeared 
normal, our data strongly support the idea 
that DNA-binding-independent actions of 
GR are sufficient to mediate epidermal 
development during embryogenesis. 
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Materials and methods 
Animal experimentation 
GR null and GRdim/dim mice have been 
previously reported (13-15). GR+/- 
hemizygous mice (C57Bl/6J) intercrosses 
were programmed to obtain GR-/-, GR+/- and 
GR+/+ mice. The same mating schedule was 
followed for GR+/dim mice to obtain GR+/+, 
GR+/dim and GRdim/dim embryos. Embryos 
were obtained by cesarean derivation at 
18.5 days post-conception (dpc; the 
morning of the day that the vaginal plug 
was seen was considered as day 0.5 pc.). 
Overall, we have analyzed 143 skin 
samples from GR-/-, GR+/- and GR+/+ 
embryos and 17 skin samples from GR+/+, 
GR+/dim and GRdim/dim embryos. In addition, 
we evaluated one litter of GR-/-, GR+/- and 
GR+/+ 16.5 dpc embryos (n = 9). For 
genotyping, DNA was isolated from mouse 
tail and analyzed by PCR, as described (13-
15). Dorsal skin was excised and either 
rapidly frozen in liquid nitrogen to obtain 
protein, fixed for immunohistochemistry or 
processed for preparation of mouse primary 
keratinocytes (MPKs). 
Mice were housed in microisolated 
boxes in which the air is filtered in both 
directions, allowing maximun isolation. 
Animal experimentation was always 
conducted with accepted standards of 
humane animal care in our registered 
animal facility (CV-46007, Centro de 
Investigación Príncipe Felipe CIPF). 
Experiments were performed in accordance 
with the “Principles of Laboratory Animal 
Care” (NIH Publication no. 85-23, revised 
1985) and with the current Spanish and 
European normative which governs research 
with animals (Real Decreto 1201/2005, 
B.O.E. #252, 10 of October, 2005 and 
Convenio Europeo 1-2-3 del 18/3/1986). 
 
Antibodies 
The antibodies used included rabbit 
polyclonal antibodies to GR (sc-1004), 
ERK (sc-154), JNK (sc-474), p-c-jun (sc-
822), β-catenin (sc-7199), c-myc (sc-788), 
and caspase-14 (sc-5628) from Santa Cruz 
Biotechnology, Inc., (Santa Cruz, CA). 
Antibodies against c-jun (#9165), p-ERK 
(Thr202/Tyr204) (#4376) and p-JNK 
(Thr183/Tyr185) (#9251) were purchased 
from Cell Signaling (Cell Signaling 
Technology Inc., Beverley, MA). E-
cadherin (610181), plakoglobin (610253) 
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and desmoglein-1 (610273) antibodies were 
from BD transduction Laboratories (BD 
Biosciences). An antibody against actin (A-
2066, Sigma Chemical Co., St. Louis, MO) 
was used for loading control. Secondary 
peroxidase-conjugated anti-rabbit antibody 
was from Amersham (Aylesbury, UK) and 
secondary peroxidase-conjugated anti-
mouse antibody and biotin-conjugated anti-
rabbit or anti-mouse antibodies from 
Jackson ImmunoResearch (Jackson 
ImmunoResearch Laboratories, Inc. West 
Grove, PA). 
Antibodies against keratin K5 
(PRB-160P), K6 (PRB-169P), K10 (PRB-
159P), loricrin (PRB-145P), filaggrin 
(PRB-417P) and involucrin were from 
Covance (Babco, Berkeley, CA). 
 
Histological and Immunohistochemical 
analysis 
Whole embryos and skin samples were 
fixed in 4% paraformaldehyde (PFA) or 
70% ethanol and embedded in paraffin. 
Consecutive 3 to 4 µm-thick sections were 
obtained. For histopathology, sections were 
stained with hematoxylin/eosin (H&E). 
Prior to immunostaining, paraffin sections 
were dewaxed and microwaved in 10 mM 
citrate solution. For immunohistochemistry, 
paraffin sections were blocked with 5% 
fetal bovine serum, and then incubated with 
the primary antibody for at least one hour. 
Slides were washed three times with PBS, 
and then incubated with conjugated 
secondary antibodies for 1 h. Finally, the 
reaction was visualized with the Avidin-
Biotin-Complex (ABC) kit from DAKO 
(Vectastain Elite, Vector Laboratories, Inc, 
Burlingame, CA) using diamino-benzidine 
as chromogenic substrate for peroxidase. 
Slides were mounted and analyzed by light 
microscopy (Leica DM RXA2), and 
microphotographs were taken at 40x 
magnification, unless otherwise indicated.  
 
In vivo epidermal BrdU labeling 
Epithelial cell proliferation was measured 
by i.p. injection of BrdU (130  µg/g of body 
weight, Roche) into pregnant female mice 1 
h before sacrifice. BrdU incorporation was 
detected by immunohistochemistry of 
paraffin-embedded sections using a mouse 
anti-BrdU monoclonal antibody (biotest, 
Roche). The number of BrdU-positive cells 
and the number of total cells was 
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determined per 200 µm of interfollicular 
epithelium in each section. Experiments 
were performed at least in five individuals 
of each genotype and differences were 
assessed by using the t test, with statistical 
significance when p < 0.05.  
 
Morphometric analysis 
Determination of the average number of 
HF, HF length and epidermal width was 
performed using 4 µm-thick skin paraffin 
sections from 16.5 dpc and 18.5 dpc 
embryos stained with hematoxilin/eosin and 
counting at least 10 individual fields of 
1mm per slide using the software 
MetaMorph (Premier Offline 7.0, 
Molecular Devices). Experiments were 
performed at least in five individuals of 
each genotype and differences were 
assessed by using the t test, with statistical 
significance when p < 0.05.  
 
Permeability barrier assays 
18.5 dpc embryos were collected, 
euthanized and submerged in methanol for 
3 min. The embryos were placed in a 0.1% 
solution of touidine blue dye in PBS for 2 
min, washed several times in PBS, dried 
and photographed. 
 
Transmission Electron Microscopy (TEM) 
studies 
Skin samples were spread on the bottom of 
a 12well-plate, washed in PBS and fixed in 
2.5% glutaraldehyde/2.5% PFA/PBS pH 
7.2 for 15h at 20º C. Skin samples were 1 h 
postfixed with 1% OsO4/PBS in the dark at 
4ºC followed by dehydration in an 
ascending water/acetone series and 
embedded in AGAR 100 epoxy resin 
(AGAR SCIENTIFIC). The resin was 
allowed to polymerize for 2 days at 60º C in 
flat embedding moulds. Sections were 
obtained by an ultramicrotome 
(REICHERT ULTRACUT S; LEICA) and 
stained with 2% uranyl acetate and lead 
citrate at various concentrations. Sections 
were examined with a transmission electron 
microscope (CEM 902A; Zeiss) at an 
acceleration voltage amounted to 80 kV 
 
MPK isolation, culture and treatments 
18.5 dpc embryos were sacrificed by CO2 
asphyxiation, their bodies were rinsed in 
70% ethanol and limbs and tail were 
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removed; tails were used for PCR 
genotyping. Skin was peeled off, rinsed in 
PBS and then incubated in 0.25% trypsin at 
4ºC overnight. The epidermis was separated 
from dermis with forceps, minced and 
homogenized in complete low calcium 
medium by vigorous shaking 10 min at 4ºC. 
The filtered solution contained MPKs, 
which were collected by centrifugation. 
MPKs were pooled (two mice of each 
genotype) and 106 cells were plated into one 
35 mm diameter collagen coated petri dish 
(BD Biosciences) and cultured at 37ºC in 
standard medium. After 24 h, the medium 
was replaced with complete low calcium 
medium and cells were grown until 
subconfluency. Cells were refed every other 
day. The composition of standard medium 
was: Essential modified Eagle´s medium 
EMEM (BioWhitakker, Inc., Walkersville, 
MD), supplemented with 4% fetal calf 
serum (FCS, BioWhitakker, Inc.) plus 0.6 
mM Ca2Cl and antibiotics. To prepare low-
calcium medium, FCS was depleted of 
divalent cations by treatment with Chelex 
deionizing resin (BioRad, Hempstead, UK) 
and supplemented with Ca2Cl to a final 
concentration of approximately 0.05 mM. 
EGF (Sigma, St. Louis, MO) (10 ng/ml) 
and antibiotics were added to growth 
medium.  
Dexamethasone (Dex, Sigma, St. 
Louis, MO, 1 µM) or vehicle was added for 
the indicated times to confluent wt MPKs 
that had been incubated in charcoal-stripped 
serum overnight to deplete steroid 
hormones. Then, cells were PBS washed 
and either total RNA or whole cell extracts 
were isolated to check caspase-14 mRNA 
levels by semiquantitative RT-PCR using 
primers previously described (16) and 
caspase-14 and filaggrin expression by 
immunoblotting. Experiments were 
performed in triplicate and mean value ± 
SD estimated. 
Phorbol 12-myristate 13-acetate 
(PMA, Sigma, St. Louis, MO) or vehicle 
were added to subconfluent MPKs at a final 
concentration of 100 ng/ml for 1 h. After 
this time, cells were either fixed for 
ERK1/2 and p-ERK1/2 immunolocalization 
or washed with cold PBS and then lysed to 
prepare whole cell extracts. Experiments 
were performed in triplicate and mean 
value ± SD estimated. 
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In vitro differentiation of MPKs 
To assess in vitro differentiation, equal 
numbers of MPKs were plated and grown 
in coverslips to confluency under low 
calcium (0.05 mM) conditions and then 
shifted to high calcium (1.2 mM) for 24 h 
or 48 h. Differentiation of wt and GR-/- 
keratinocytes was assessed by phase 
contrast and expression of K10 and 
involucrin, as markers of early and late 
differentiation, was examined by 
immunofluorescence. 
 
BrdU immunofluorescence 
To determine BrdU incorporation in MPKs, 
cells were seeded on glass coverslips until 
subconfluency and then incubated with 3 µl 
of BrdU (biotest, Roche, 1µg/µl) for 3h at 
37ºC. After fixation, cells were 
permeabilized, treated with HCl 2N for 30 
min and then, blocked and incubated with 
anti-BrdU antibody (biotest, Roche) 
followed by anti-mouse-FITC. Coverslips 
were mounted with polyvinil-alcohol-
DABCO (Fluka, Sigma-Aldrich Chemie, 
GmbH, Switzerland) containing DAPI and 
samples were visualized under a 
fluorescence microscope (Leica DM 
RXA2). Positive nuclei were counted (at 
least 500 cells, 4 coverslips per genotype) 
in five independent experiments and 
percentages of BrdU-positive cells ± SD 
determined. Routinely, controls of staining 
specificity were performed by using 
preimmune serum and the secondary 
antibodies, which gave no signal (not 
shown).  
 
Analysis of apoptosis in tissue sections and 
cultured keratinocytes 
To detect individual apoptotic cells in 
paraffin-embedded tissue sections and 
MPKs, the In Situ Cell Death Detection kit 
(Roche) was used, following 
manufacturer´s recommendation. Paraffin 
sections immersed in 0.1 M citrate buffer, 
pH 6 were microwave-irradiated for 5 min, 
and then rinsed with PBS prior to the 
TUNEL reaction. Four 16.5 dpc embryos of 
each genotype were examined. 
MPKs isolated from GR-/- and 
GR+/+ embryos (four of each genotype) 
were seeded on glass coverslips until 
subconfluency and treated as indicated. 
Cells were fixed and permeabilized, and 
incubated with the TUNEL reaction 
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mixture for 1 h at 37ºC in the dark. Sections 
were mounted with DAPI and samples 
visualized under a fluorescence microscope 
(Leica DM RXA2) to determine the 
percentages of apoptotic cells. As a positive 
control, wt MPKs were treated with vehicle 
or TNF-α (100 mg/ml) plus cycloheximide 
(CHX, 1 µg/ml, Sigma) for 16h, as 
previously described (17). When indicated, 
the ERK inhibitor PD098059 (50 µM, 
Calbiochem, San Diego, CA) was added for 
16h. Quantitation of single apoptotic cells 
represents the mean value ± SD estimated 
obtained from three different experiments 
with MPKs using three replicates for each 
experimental condition. Differences were 
assessed by using the t test, with statistical 
significance when p < 0.05. 
 
Immunoblotting 
Whole cell extracts (20 µg) were prepared 
as previously described (15), boiled in 
Laemmli buffer and separated on 10% 
sodium dodecyl sulfate-polyacrylamide gels 
(SDS-PAGE), then transferred to 
nitrocellulose filters (Hybond ECL, 
Amersham, Aylesbury, UK). Filters were 
blocked with 5% nonfat dry milk in PBS-
0.1% Tween 20 at 4º C overnight, washed 
three times in PBS-0.1% Tween 20 and 
incubated with the indicated antibodies. 
After washing, membranes were incubated 
with a peroxidase-conjugated secondary 
antibody (Amersham), washed again, and 
analyzed using the enhanced 
chemiluminiscence method (ECL, 
Amersham), according to manufacturer’s 
recommendations. The membranes were 
also stained with Ponceau S (Sigma 
Chemical Co., St. Louis, MO) to verify 
equal protein loading and transfer. 
Specific bands were scanned by 
using Image Quant (Amersham), 
quantitated with Quantity One Software 
(BioRad) and represented as graph bars. 
Values for control samples (basal protein 
levels in wt skin) were arbitrarily set as 1 
and the values in GR-/- were expressed as 
relative to wt. Experiments were performed 
at least in three individuals of each 
genotype and differences were assessed by 
using the t test, with statistical significance 
when p < 0.05. 
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Results 
GR is required for epidermal and hair 
follicle differentiation during 
embryogenesis 
To investigate the consequences of GR 
loss-of-function in skin development, we 
analyzed the progeny of GR+/- hemizygous 
mice intercrosses at late embryo stages. 
Macroscopical observation of 16.5 and 18.5 
dpc embryos revealed shiny thinner skin of 
GR-/- mice, in contrast to their wild-type (wt 
or GR+/+) littermates, whereas GR+/- pups 
were indistinguishable from wt. Skin of GR-
/-
 mice was easily damaged by mechanical 
stress, such as forceps manipulation used 
for cesarean derivation. Histological 
analysis by H&E staining of paraffin-
embedded skin sections from 16.5 and 18.5 
dpc embryos revealed that the lack of GR 
resulted in altered skin development with 
incomplete epidermal stratification and 
dramatically abnormal differentiation (Fig. 
1). The epidermis of wt late embryos is 
organized as stratified epithelia composed 
of a single basal cell layer and six-to eight 
suprabasal cell layers, including the spinous 
layer (SL), the granular layer (GL) 
containing keratohyalin granules and the 
outermost layer, the stratum corneum (SC). 
At 16.5 dpc, epidermal maturation is 
characterized by the appearance of the GL 
and SC, key to the formation of a 
competent skin barrier, which is established 
at 18.5 dpc. In sharp contrast to wt late 
embryos, 16.5 and 18.5 dpc GR-/- epidermis 
was highly immature and featured only 
three to four suprabasal layers with an 
abnormal high number of apoptotic 
keratinocytes (arrows) in the lower 
suprabasal layers (Fig. 1, compare C and F 
with A and D). Apoptotic keratinocytes 
were further identified by TUNEL staining 
in the suprabasal layers of the GR-/- skin 
sections. In contrast, wt skin displayed non- 
apoptotic cells or few scattered apoptotic 
cells (Fig. 1G and data not shown). 
Moreover, both the GL and the SC were 
barely detected. However, GR+/- skin 
appeared indistinguishable from wt (Fig. 
1B, E). 
We thus examined the markers of 
later stages of terminal differentiation 
filaggrin, loricrin and involucrin in 18.5 dpc 
embryos (Fig. 2). Filaggrin is specifically 
expressed in the GL of the epidermis and 
loricrin and involucrin constitute the major 
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cornified envelope precursors. Remarkably, 
the expression of all these markers was 
either residual or absent in GR-/- mice, in 
contrast to GR+/- and wt littermates (Fig. 2). 
Notably, the HFs in GR-/- skin had a 
more rudimentary appearance than wt and 
heterozygous littermates. In 18.5 dpc 
embryo skin, K6 was expressed at the inner 
root sheath of HF but absent in the 
interfollicular epidermis in GR+/+ and GR+/-, 
however, it was partially lost in GR-/- HFs, 
suggesting delayed differentiation (Fig. 2). 
We next quantitated the number of 
anagenic HF as well as HF length in dorsal 
skin of GR-/-, GR+/- and GR+/+ mice by 
morphometric analysis (Table 1). 
Surprisingly, neither the density nor the 
average length of HF was significantly 
changed, as assessed by H&E staining 
(Table 1). 
We also performed electron 
microscopy studies of GR+/+ and GR-/- 18.5 
dpc epidermis (Fig. 3A-F) and found an 
abnormal morphology of keratinocytes in 
the BL, as well as abnormally differentiated 
suprabasal keratinocytes. Remarkably, the 
GL and SC were poorly differentiated and 
intercellular spaces were increased in GR-/- 
epidermis (Fig. 3B, asterisks). Keratohyalin 
granules appeared rudimentary with 
decreased electron density (Fig. 3D, arrows, 
compare with C) and the SC showed 
parakeratotic squames with increased 
electron density and contained cellular 
debris, a feature of incomplete cellular 
death (Fig. 3D asterisks, compare with C). 
Desmosomes (indicated by arrows) could 
be detected in all epidermal layers of GR+/+ 
mice (Fig. 3E), whereas only few 
desmosome-like structures could be located 
in suprabasal layers of GR-/- embryo skin 
(Fig. 3F). Given that epidermal terminal 
differentiation was severely impaired in 
GR-/- mice, we evaluated the functionality 
of the permeability barrier in 18.5 dpc 
embryos by toluidine blue staining (Fig. 
3G). As expected, epidermal maturation 
was complete in wt embryos at this stage 
and, consequently, epidermal regions that 
have acquired barrier appeared as white. In 
contrast, some regions around the paws, 
forelimbs, chin and neck of GR-/- embryos 
were visualized as blue, thus evidencing a 
compromised skin barrier function (Fig. 
3G). Overall, our results indicate that GR is 
required for keratinocyte terminal 
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differentiation and thus, skin barrier 
competence, during embryogenesis. 
Since processing of procaspase-14 
seems to precede the final steps of 
keratinocyte differentiation (5), we 
investigated whether its activation was 
altered in GR null mice. According to 
previous reports, caspase-14 cleavage, 
represented by the large subunit p20, was 
already detected in 16.5 dpc wt epidermis 
although increased processing was 
observed in 18.5 dpc skin (Fig. 4A, upper 
panel). This correlated with the appearance 
of mature filaggrin at 16.5 and 18.5 dpc, as 
detected by immunoblotting (Fig. 4A, lower 
panel, arrowhead). Unprocessed and 
incompletely processed profilaggrin is 
indicated by a bracket. In contrast, caspase-
14 processing was not detected in 16.5 dpc 
or 18.5 dpc GR null epidermises with 
undetectable levels of filaggrin at 16.5 dpc 
and only minor levels at 18.5 dpc (Fig. 4A). 
In addition, caspase-3 was not activated 
during fetal epidermis development in wt or 
GR null mice (Fig. 4B). 
In order to determine whether the 
caspase-14 expression and/or processing 
was directly regulated by ligand-activated 
GR, we examined the effect of the GC 
analog dexamethasone (Dex) on the mRNA 
and protein levels of procaspase 14 in wt 
mouse primary keratinocytes (MPKs) (Fig. 
4C-E). Our results showed that Dex, at a 
concentration inducing MPK 
differentiation, produced a two-fold 
increase in the procaspase-14 protein levels 
without eliciting its processing (Fig. 4D). 
We also checked whether Dex regulated 
caspase-14 at the mRNA level and found no 
differences in caspase-14A and -14B 
transcripts (Fig. 4E). In agreement with 
this, both caspase-14 mRNA forms were 
similar in GR-/- skin as compared to GR+/+ 
(Fig. 4E). 
 
GR inhibits keratinocyte growth in a cell-
autonomous manner. 
The high immaturity of GR-/- epidermis 
suggested a defective switch between 
proliferation and differentiation. We 
observed that immunolocalization of K5, 
normally restricted to the proliferative 
single BL (Fig. 5A, arrows), was 
abnormally found in suprabasal layers of 
GR-/- skin (Fig. 5B, arrowheads). This 
finding prompted us to examine whether 
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these K5-positive keratinocytes were 
indeed proliferating by assessing in vivo 
BrdU incorporation (Fig. 5C-E). In contrast 
to control mouse skin, in which all positive 
nuclei were located in the epidermal BL or 
in the outer root sheath of HFs (Fig. 5C, 
thin and thick arrow, respectively), we 
observed some BrdU-positive cells in the 
first suprabasal layer of GR null skin (Fig. 
5D, arrowheads), a typical feature of 
hyperproliferative skin disorders. However, 
and despite abnormal localization of 
proliferating keratinocytes, we did not find 
statistically significant changes in the 
proliferation of interfollicular GR-/- 
keratinocytes as compared with wt 
epidermis (Fig. 5E, 15.3% vs 10.8%; p > 
0.05). These findings were somehow 
unexpected since we and others previously 
reported that overexpression of GR exerts 
an anti-proliferative role in keratinocytes in 
vivo (18, 19). 
In an attempt to understand this 
apparent contradiction and to discriminate 
whether GR affects keratinocyte 
proliferation in a cell-autonomous manner, 
we isolated and cultured MPKs from 18.5 
dpc GR-/-, GR+/- and GR+/+ embryos. As 
mentioned, skin of GR-/- mice was thinner 
than that of their wt littermates and, 
accordingly, we found a reduction in the 
total yield of MPKs obtained from GR-/- as 
compared to GR+/+ epidermis, which was 
statistically significant (1.02 x 106 cells ± 
0.5 vs 1.80 x 106 cells ± 0.8; n = 70; p < 
0.05). After plating in low-calcium 
medium, the number of non-adherent cells 
found in GR-/- MPKs was higher than in 
GR+/+ epidermis (not shown). At day 3 after 
seeding, GR+/+ and GR+/- MPKs had 
reached subconfluency and appeared as 
undifferentiated cells (Fig. 5F and data not 
shown). In sharp contrast, GR-/- 
keratinocytes formed colonies, consisting of 
cells with heterogeneous size and 
morphology, where bigger cells were 
located at the borders (Fig. 5F, thin arrows) 
and smaller rounded cells at the center (Fig. 
5F, thick arrows), with many cells 
exhibiting apoptotic features (Fig. 5F, 
arrowheads; see also Fig. 8).  
When cell growth was assessed in 
MPKs (Fig. 5G), we found a robust 
increase (28,12%) in the proliferation rate 
of GR-/- cells as compared with wt 
keratinocytes (12,47%). Collectively, and 
 16
despite GR-/- epidermis showed no overall 
changes in proliferation, our data indicate 
that GR regulates keratinocyte growth in a 
cell-autonomous manner. 
 
In vitro differentiation of GR-/- 
keratinocytes 
The lack of differentiation of GR-/- 
keratinocytes in vivo (Figs. 1-3) could be 
due to an intrinsic defect of these cells or to 
an inappropriate calcium supply, which is 
required for normal differentiation of 
keratinocytes. To examine this, we cultured 
MPKs isolated from GR-/- and wt littermates 
and analyzed their responses to an elevated 
concentration of calcium (Fig. 6). As 
reported (20), high calcium induced evident 
changes in wt keratinocyte morphology, 
that appeared as flat and enlarged cells, 
with numerous cell-cell contacts and 
formed epithelial sheets as differentiation 
proceeded (Fig. 6, GR+/+ Ca2+ 24 h, 48 h). 
Surprisingly, the presence of high calcium 
in GR-/- MPKs caused similar 
morphological changes as compared to wt 
keratinocytes. Moreover, the augmented 
expression of keratins that are markers of 
differentiation, normally induced in wt 
MPKs by high calcium treatment, was 
similarly induced in cultured GR-/- 
keratinocytes (Fig. 6). Given that epidermal 
differentiation is severely impaired in GR-/- 
embryos (Fig. 1-3) but cultured GR-/- 
keratinocytes differentiate upon high 
calcium, our data suggest that a defect in 
the formation of the calcium stimulatory 
system of GR-/- skin exists, that can be 
overcome in cell culture by adding calcium. 
 
Contribution of ERK to the impaired 
keratinocyte function of GR-/- mice 
Given the key role of MAPKs in 
keratinocyte proliferation (21) and 
differentiation and since GR negatively 
regulates their function (22), we 
investigated MAPKs expression and 
function in GR null skin by immunoblotting 
and immunostaining. We first checked the 
expression of total protein and 
phosphorylated (p-) isoforms of the 
extracellular signal-regulated kinase 1/2 
(ERK1/2) and c-jun-N-terminal kinase 
(JNK) in GR+/+ and GR-/- skin from 18.5 
dpc embryos (Fig. 7). Despite ERK1/2 
protein levels being unaltered, p-ERK1/2 
(Thr202/Tyr204, which leads to its 
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activation) was increased an average 3.5-
fold in GR-/- skin as compared to controls 
(Fig. 7B). Immunostaining showed a 
marked augment of both cytosolic and 
nuclear p-ERK staining in GR-/- epidermal 
keratinocytes (Fig. 7C, p-ERK). In contrast 
to control epidermis, where p-ERK 
predominantly localized to GL nuclei, p-
ERK was detected throughout all 
suprabasal layers. However, JNK and p-
JNK protein levels were unchanged in GR-
deficient skin with no major changes in 
their cellular distribution (Fig. 7A, C). 
Moreover, phosphorylation of c-jun on 
residues S63/S73 as well as total c-jun 
protein levels remained unchanged in GR-/- 
epidermis relative to wt (Fig. 7A, C). 
We next used immunofluorescence 
staining to examine ERK activation in 
normally growing keratinocytes obtained 
from GR-/- and GR+/+ mice. In wt 
keratinocytes, total ERK was 
predominantly localized in the cytoplasm 
whereas anti–p-ERK gave only weak 
staining above background (Fig. 8A, 
GR+/+). In GR-/- MPKs, expression of total 
ERK was similar than in controls, however, 
the majority of cells showed a positive 
nuclear signal for p-ERK (Fig. 8A, GR-/-). 
The enhanced activation of ERK in cultured 
keratinocytes from GR-/- mice under non 
stimulated conditions was confirmed by 
immunoblotting using whole cell extracts 
(Fig. 8B). Quantitation of specific bands 
revealed an average 3.2-fold increase of p-
ERK levels in GR-/- MPKs as compared to 
wt keratinocytes. When MPKs were treated 
with PMA, a known inducer of ERK 
activity, we observed a similar increase of 
p-ERK in both GR+/+ and GR-/- MPKs (Fig. 
8C). Collectively, our data support a key 
role for GR in controlling keratinocyte 
function through inhibition of the 
MAPK/AP-1 signaling pathway. 
To further demonstrate the 
contribution of ERK activation in the 
impaired keratinocyte function of GR-/- 
mice, we analyzed the apoptotic rate of 
cultured keratinocytes and the 
consequences of adding the 
pharmacological ERK inhibitor PD098059, 
which has been used extensively as 
selective inhibitor of the activation of the 
ERK-1/2 kinase, MEK-1, to block ERK-1/2 
phosphorylation and activation in 
keratinocytes and other cell types (23, 24). 
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Cultured keratinoctes were grown 
in the absence or presence of PD098059 (50 
µM) and apoptosis was evaluated by 
TUNEL immunostaining in wt and GR-/- 
MPKs, and quantitated (Fig. 8D). Basal 
apoptotic rate in wt keratinocytes (6%) was 
reduced in the presence of PD98059 (3%). 
In contrast to control cells, GR-/- MPKs 
exhibited an increase of apoptosis of 
approximately 16%. Moreover, inhibition 
of ERK reduced the augmented apoptosis 
of GR-/- keratinocytes (10%). As a positive 
control for apoptosis, we treated wt 
keratinocytes with TNF-α plus CHX for 
16h, which augmented apoptosis 
approximately by six-fold (30%). Our 
results with pharmacological inhibitors of 
ERK activity provide evidences that the 
increased apoptosis rate in GR-/- 
keratinocytes is, at least partially, linked to 
augmented ERK activation in these cells, in 
agreement with previous reports (25). 
To further investigate the 
mechanisms underlying GR function in skin 
development, we used GRdim/dim mice 
carrying a point mutation that impairs 
dimerization-induced DNA-binding of the 
GR (15). Our histological analysis revealed 
no differences between GRdim/dim, GR+/dim 
and wt littermates either in epidermal or HF 
formation (Fig. 9A). In addition, we found 
no differences in the expression and 
localization of the markers of keratinocyte 
proliferation and differentiation K5, K10 
and loricrin (Fig. 9B). Collectively, data 
obtained from the analysis of GRdim/dim 
embryos along with those regarding the role 
of ERK in GR-/- skin support the idea that 
GR regulates epidermal formation during 
embryogenesis most likely through DNA 
binding-independent actions. 
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Discussion 
Role of GR in epidermal proliferation and 
differentiation 
Although skin serves additional functions, 
its primary purpose is to form a protective 
barrier to harmful environmental stimuli. 
The epidermis is a squamous stratified 
epithelium that matures following through 
complex processes involving a correct 
balance between proliferation, 
differentiation and apoptosis. However, the 
mechanisms of stratification and, in 
particular, the effects of GC action on skin 
development are still poorly understood (3). 
We previously reported that overexpression 
of GR in epidermal basal cells by means of 
the K5 promoter (K5-GR mice) produced 
strong epidermal hypoplasia and dysplastic 
HFs during skin development (18, 26). 
However, the impact of GR loss-of-
function in skin development had remained 
unexplored until now. In the present work, 
we demonstrate that GR-/- skin, but not 
GRdim/dim, featured a highly disorganized 
architecture with incomplete epidermal 
stratification and cornification defined by 
the lack of terminal differentiation (Figs. 1-
4 and 8). Although many key processes that 
are impaired in the GRdim/dim mice (15, 27) 
are most likely due to defective DNA 
binding-dependent transactivation of GR, 
neither A458T nor other GR dimerization 
mutants are globally deficient in 
transactivating via GR at promoters, as 
demonstrated by several reports (28, 29). 
This implies that the mechanisms through 
which GR controls keratinocyte function 
could depend on nontranscriptional events, 
on transrepression, or on transactivation of 
genes with a more complex GRE 
configuration, that can be regulated in the 
GRdim/dim mice, as occurs with PNMT gene 
(28, 29). 
Skin barrier acquisition starts at 
16.5 dpc on the dorsal surface and spreads 
laterally to the ventral surface in a patterned 
fashion (3). Our present findings 
demonstrate that GR is required for 
epidermal terminal differentiation and skin 
barrier function (Figs. 1-3). However, 
cultured GR-/- MPKs differentiated in vitro 
upon high calcium, thus supporting the 
hypothesis that a defect in the formation of 
the calcium stimulatory system of GR-/- skin 
exists, that can be overcome in cell culture 
by adding calcium. 
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A recent report has identified the 
transcriptomic profile of cultured human 
keratinocytes in response to GCs (19). In 
this work, the authors propose that GCs 
may have a dual effect on epidermal 
differentiation by promoting the late stages 
of terminal differentiation and, at the same 
time, inhibiting the early stages. In 
particular, several genes encoding for 
enzymes involved in SC formation were 
identified as GC-regulated, such as 
transglutaminase 1, filaggrin and 
corneodesmosin (19). These findings are in 
agreement with our in vivo model. 
On the other hand, the ultrastructure 
of GR-/- embryo skin featured revealed a 
reduced number of desmosomes (Fig. 3). 
Previous reports indicated that GCs up-
regulate several adhesion molecules, 
including markers of adherens junctions (E-
cadherin), desmosomes (desmoglein-1) or 
both (plakoglobin)(19). We examined the 
expression of these markers in GR-deficient 
skin and found reduced levels of these 
molecules as compared to controls (not 
shown). 
Remarkably, GR knock-out 
embryos exhibit increased levels of ACTH 
and corticosterone as a compensatory 
mechanism for the GR loss-of function 
(13). Our results indicate that excess steroid 
hormones rather correlate with defective 
epidermal maturation than cause these 
defects. Accordingly, impaired proliferation 
and apoptosis as well as constitutively 
augmented ERK activity was found in GR-/- 
keratinocytes, which suggests that the 
observed effects are independent of 
increased hormone levels. 
Another relevant finding of this 
study reveals that GR loss-of-function 
correlates with the lack of processing of 
caspase-14, which prevents the formation 
of mature filaggrin and thus, the appearance 
of SC providing mammals with a 
competent epidermal barrier function. Our 
results show that ligand-activated GR 
regulates caspase-14 expression in cultured 
keratinocytes at the post-transcriptional 
level. The effect of Dex on caspase-14 
expression occurred at concentrations 
inducing keratinocyte differentiation. 
Noteworthy, the regulation of caspase-14 in 
vivo was also post-transcriptional since no 
changes in caspase-14 transcripts were 
found in GR-/- skin as compared to GR+/+ 
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mice (Fig. 4). The importance of caspase-
14 as a GR target is supported by the recent 
findings in caspase-14-/- mice. These mice 
exhibited reduced skin-hydration levels and 
increased water loss and an altered 
profilaggrin processing pattern that could 
explain the observed phenotype (30). 
However, other proteolytic enzymes of this 
family, such as caspase-1 and -4 have been 
described as GC-targets in keratinocytes 
(19). 
Remarkably, and despite the 
reported anti-proliferative role of GR, GR 
null mice did not show overall increased 
epidermal proliferation in vivo (Fig. 5). 
However, we observed abnormal 
proliferating suprabasal keratinocytes in 
GR-/- skin that indicated a defective switch 
between proliferation and differentiation. 
When MPKs were cultured, an increased 
proliferation rate of GR-/- keratinocytes as 
compared to wt was apparent (Fig. 5), thus 
demonstrating that GR regulates 
keratinocyte proliferation in a cell-
autonomous manner. 
 
GR modulates ERK activity to regulate 
keratinocyte function 
Since MAPK/AP-1 signaling pathway plays 
a relevant role in keratinocyte biology 
(reviewed in 31), and given that GR inhibits 
MAPK function in several cell types, we 
analyzed whether ERK and JNK activities 
were altered in GR-deficient keratinocytes. 
We found an increase in p-ERK1/2 but not 
JNK activity in GR-/- keratinocytes by 
immunoblotting and immunostaining 
techniques (Figs. 6 and 7). It is assumed 
that ERK1 and ERK2 isoforms play unique 
roles since ERK1-deficient mice are viable 
whereas ERK2 knock out mice are 
embryonic lethal (32, 33). However, one 
should also consider that a threshold of total 
ERK activity may be required, at least in 
skin, since in this tissue, ERK2 cannot 
compensate for the loss of ERK1 (33). 
Given that both p-ERK1/2 isoforms were 
augmented in the epidermis as a 
consequence of GR loss-of-function, our 
data suggest that the hormone receptor 
modulates both activities. Recent work has 
highlighted the relevance of ERK1 in skin 
homeostasis and skin tumor development 
(25). ERK1-deficient mice showed reduced 
proliferation of basal keratinocytes upon 
TPA treatment and resistance to 
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development of skin papillomas induced by 
7,12-dimethylbenz(a)anthracene (DMBA)-
TPA protocol (25). Worth noting, the 
delayed tumor appearance and reduced 
tumor number and size found in ERK1 null 
mice was also reported in K5-GR 
transgenic mice that were subjected to 
different protocols of tumor formation (34, 
35). Collectively, the existing data argue in 
favour of antagonistic functions of GR and 
ERK in keratinocyte proliferation. 
On the other hand, ERK1 has also 
been implicated in modulating the 
proliferation/apoptosis balance, based on 
the increased epidermal thickness and the 
resistance of ERK1-deficient MPKs to 
apoptosis. In wt skin, p-ERK was 
predominantly localized to nuclei in the 
granular layer (Fig. 7), which would fit with 
the proposed role of ERK in keratinocyte 
apoptosis. In contrast, p-ERK was detected 
throughout all suprabasal layers in GR-/- 
skin and, remarkably, most of p-ERK 
staining was detected in GR-/- keratinocytes 
exhibiting apoptotic features (Fig. 7). 
According with this, the phenotype of 
MPKs from GR null mice (increased 
growth and apoptotic features; Figs. 5 and 
8) was the opposite of that found in ERK 
null primary keratinocytes (reduced growth 
and resistance to apoptotic signals; 25). The 
fact that constitutive ERK activation was 
found in normally growing keratinocytes 
from GR-/- mice by immunofluorescence 
and immunoblotting (Fig. 8) further 
supports a role for GR in controlling ERK 
function. Given that GR-/- MPKs exhibited 
increased apoptosis, which was partially 
reduced by a selective ERK inhibitor, as 
demonstrated by TUNEL assays, our data 
reinforce that GR plays a role in 
keratinocyte apoptosis through regulation 
of the ERK function (Fig. 8D, E). Our 
results are in agreement with the reduced 
apoptosis response of ERK-/- keratinocytes 
both in vivo in total skin, and in culture 
(25). 
Since the role of ERK2 has not 
been yet defined, it cannot be ruled out that 
the observed changes in this isoform 
modulate other aspects of keratinocyte 
function, such as differentiation. In this 
regard, previous studies in primary human 
keratinocytes have shown that sustained 
activity of ERK suppresses and ERK 
inhibition induces differentiation (36). 
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Surprisingly, we did not detect 
major changes in either the protein levels or 
cellular distribution of JNK, p-JNK, c-jun 
and p-c-jun in GR-deficient skin relative to 
wt (Fig. 6). This was rather unexpected 
given the reported negative cross-talk 
between GR and JNK in many cell types, 
including keratinocytes (11, 22). A recent 
work by Gazzel and coworkers has 
examined the transcriptomic profile of 
human keratinocytes upon pharmacological 
inhibition of the JNK pathway (37). The 
outcome of this study is that JNK does not 
directly regulate many cell-cycle and 
proliferation genes but rather modulates 
proliferation as a consequence of 
keratinocyte differentiation.  
We previously reported that GR-
mediated repression of AP-1 target genes in 
skin upon phorbol ester treatment occurred 
through the DNA binding-independent 
function of GR (38). However, and despite 
many AP-1 target genes in the epidermis 
include members of the cytokeratin gene 
family that are repressed by GR (22, 39), 
we did not observe changes in the level of 
these transcripts (not shown). It is feasible 
that GR play differential roles during 
epidermal development as compared to 
stress responses in adult individuals. 
Overall, our present findings demonstrate 
that GR is required for epidermal terminal 
differentiation and skin barrier competence 
during embryo development. 
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Figure legends 
Fig. 1. Loss of GR results in immature skin with incomplete stratification and dramatically 
abnormal differentiation and reduced number of hair follicles in 16.5 and 18.5 dpc embryos. 
Histological analysis by H&E staining in paraffin-embedded skin sections revealed thinner 
undifferentiated skin in GR-/- embryos (C, F) as compared with GR+/- (B, E) and wild-type 
(GR+/+) littermates (A, D). Note the thinner epidermis (double headed arrow) and the high 
number of apoptotic keratinocytes (arrows) in GR-/- embryos. Dotted line delineates the 
basement membrane. BL, basal layer; SL: spinous layer; GL, granular layer; SC, stratum 
corneum. Bars: 50 µm. (G) TUNEL staining was performed in paraffin-embedded skin sections 
from GR+/+ and GR-/- 16.5 dpc embryos. Dashed lines delineate the basement membrane and the 
most outer layer of the epidermis. Non-apoptotic keratinocytes were found in GR+/+ skin 
whereas numerous TUNEL-positive apoptotic keratinocytes (arrows) were detected in the lower 
suprabasal layers of GR-/- epidermis. 
 
Fig. 2. Lack of terminal differentiation and abnormal HF differentiation in GR-/- epidermis. 
Expression of filaggrin, loricrin, involucrin and K6 was determined in paraffin-embedded dorsal 
skin of 18.5 dpc GR-/-, GR+/- and wild-type (GR+/+) littermates by immunostaining using specific 
antibodies. Arrows in GR+/+ and GR+/- point to the expression of K6 at the inner root sheath of 
HF. Bars: 50 µm. 
 
Fig. 3. Skin barrier competence is impaired in GR-/- mice. A) Differential ultrastructure of 
epidermis of GR+/+ (A, C, E) and GR-/- (B, D, F) 18.5 dpc embryos. Electron micrographs 
demonstrated the presence of basal (BL) and spinous layers (SL) in both GR+/+ and GR-/- 
epidermises; however, granular layer (GL) and the stratum corneum (SC) in GR-/- skin appeared 
poorly differentiated (B). Intercellular spaces were increased in GR-/- epidermis (B, asterisks). 
Dashed line marks the epidermal-dermal boundary. Note that in GR-/- skin, keratohyalin 
granules appeared rudimentary with decreased electron density (D, arrows) whereas SC showed 
increased electron density and contained cellular debris (D, asterisks). Desmosomes (E, F, 
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arrows) could be easily detected in GR+/+ skin in BL, SL and GL, whereas in suprabasal layers 
of GR-/- epidermis, only few desmosome-like structures could be located (F). Bars: 20 µm (A, 
B, E, F), 1 µm (C, D). G) Permeability barrier in 18.5 dpc embryos, as assessed by toluidine 
blue staining. Epidermal maturation was complete in wt embryos at this stage (white) whereas 
some regions around the paws, forelimbs, chin and neck of GR-/- embryos were visualized as 
immature and permeable regions (blue). 
 
Fig. 4. Caspase-14 processing and stratum corneum (SC) formation in late embryo epidermis 
from wt and GR-/- mice. (A) Total skin protein extracts from 16.5 dpc and 18.5 dpc embryos 
were subjected to immunoblotting using anti-caspase-14 and anti-filaggrin antisera. The size of 
molecular weight markers is indicated on the left. Procaspase-14 (p30) and the large subunit 
(p20) of caspase-14 are indicated by an arrow and arrowhead, respectively. Unprocessed and 
incompletely processed profilaggrin is indicated by a bracket and mature filaggrin is indicated 
by an arrowhead. (B) Caspase-14 and caspase-3 expression in 18.5 dpc epidermises from wt and 
GR-/- mice were analyzed by immunostaining using specific antibodies. Note that, contrary to 
caspase-14, caspase-3 was not detected in developing fetal mouse epidermis. Bars: 50 µm. (C) 
Mouse primary keratinocytes (MPKs) obtained from wt mice were cultured until confluency, 
then treated with either vehicle (-) or Dex 1 µM for 48 h to induce differentiation. Bar: 50 µm. 
(D) Protein lysates were prepared from vehicle- or Dex-treated MPKs as well as 16.5 dpc GR-/- 
and wt skin to examine caspase-14 and filaggrin expression. (E) Total RNA was isolated from 
vehicle- or Dex-treated MPKs and 16.5 dpc GR-/- and wt skin to check caspase-14 mRNA 
transcripts by RT-PCR using specific primers. 
 
Fig. 5. Augmented keratinocyte proliferation in GR-/- MPKs. (A) K5 immunostaining in GR+/+ 
(A) and GR-/- (B) skin. Epidermal proliferation was assessed in GR+/+ (C) and GR-/- (D) 
littermates by immunostaining using an anti-BrdU antibody. All positive interfollicular 
keratinocytes (arrows) detected in wt epidermis were located in the epidermal basal layer 
whereas suprabasal positive nuclei (arrowhead) were also seen in GR-/- embryos. (E) 
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Quantitation of positive-BrdU cells was expressed as the percentage of total number of 
counterstained nuclei; p > 0.05; n = 11. (F) MPKs obtained from GR+/+ and GR-/- littermates 
were cultured for 3 days. At the time of subconfluency, MPKs from GR-/- mice formed 
heterogeneous colonies with smaller rounded cells at the center (arrows) and signs of increased 
cell death (arrowhead). (G) BrdU incorporation was determined by immunofluorescence and 
quantitated. Percentage of positive-BrdU cells relative to total number of nuclei stained with 
DAPI was expressed; * p < 0.0001; n = 6. Bars: 50 µm. 
 
Fig. 6. In vitro keratinocyte differentiation in GR-/- MPKs. Epidermal MPKs were plated and 
grown in coverslips to confluency under low calcium (0.05 mM) conditions and then shifted to 
high calcium (1.2 mM) for 24 h or 48 h, as indicated. (A) Differentiation of GR+/+ and GR-/- 
keratinocytes was assessed by phase contrast. Bar: 50 µm. (B) Expression of K10 and 
involucrin, as markers of early and late differentiation, was examined by immunofluorescence. 
Experiments were performed in duplicate by using four mice of each genotype (n = 4). Bar: 50 
µm. 
 
Fig. 7. ERK1/2 activity is increased in 18.5 dpc GR-/- epidermis. (A) Immunoblotting using 
whole cell extracts obtained from GR+/+ and GR-/- skin was performed to check expression of 
ERK1/2, phosphorylated (p)-ERK1/2, JNK, JNK, c-jun and p-c-jun. Actin was used as a 
loading control. (B) Protein levels were normalized to actin and statistically significant 
differences calculated. Only the ratio of p-ERK relative to total ERK was found statistically 
significant; * p < 0.05; n = 5. (C) Immunostaining of GR+/+ and GR-/- skin showing localization 
of p-ERK, p-JNK an p-c-jun. ERK1/2 was constitutively increased in GR-/- epidermis. Bars: 50 
µm. 
 
Fig. 8. ERK1/2 activation in GR-/- MPKs contributes to increased keratinocyte apoptosis. (A) 
Immunofluorescence of GR+/+ and GR-/- MPKs showing localization of total and p-ERK. DAPI 
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nuclear staining is also shown. All pictures were taken at the same magnification. Bar: 50 µm 
(B) Immunoblotting using whole cell extracts obtained from MPKs from GR+/+ and GR-/-. 
MPKs were checked for expression of ERK1/2 and p-ERK1/2 in the absence or presence of 
PMA (100 ng/ml) for 1 h. Actin was used as a loading control. (C) Quantitation of B. Protein 
levels were normalized to actin and the ratio of p-ERK to total ERK was calculated and found 
statistically significant; * p < 0.05; n = 6. (D) The apoptosis rate of GR+/+ and GR-/- MPKs was 
assayed by TUNEL staining and quantitated relative to total nuclei. MPKs were grown until 
subconfluency and treated with either vehicle or the ERK inhibitor PD098059 (50 µM, 16 h). 
TNF-α (100 mg/ml) plus cycloheximide (CHX, 1 µg/ml) was added to wt MPKs for 16h as a 
positive control for apoptosis. Three different experiments using three replicates for each 
experimental condition were performed and differences assessed by the t test. Asterisks indicate 
statistically significant differences relative to wt MPKs, * p < 0.0001. Apoptotic rate of GR-/- 
MPKs treated with PD98059 also had statistical significance as compared to untreated GR-/- 
MPKs, p < 0.001. 
 
Fig. 9. Normal embryonic epidermal development of GRdim/dim mice. (A) 18.5 dpc embryos of 
the indicated genotypes were analyzed by H&E staining (n = 17). Skin development was 
impaired in GR-/- mice but normal in GRdim/dim mice as compared with wild-type (GR+/+) 
littermates. Edematous basal and lower spinous cells and high number of apoptotic 
keratinocytes (arrows) are indicated in GR-/- embryos. Bars: left panels: 100 µm; right panels: 
50 µm. (B) Immunostaining in GR+/+ and GRdim/dim 18.5 dpc embryo skin using specific 
antibodies against K5, K10 and loricrin. Bars: 50 µm. 
 
Table 1. Morphometric analysis of 18.5 dpc GR-/-, GR+/- and GR+/+ littermates Quantitation of 
hair follicle (HF) number/mm and HF average length was performed in H&E dorsal skin 
sections, as indicated in Materials and Methods (n = 4, p > 0.05). 
89.83+3.5
89.07+2.8
78.64+2.4
9.24+1.2
8.41+2.1
10.8+4.8
GR +/+
GR +/-
GR -/-
HF average length (µm) 
(Mean + SD)
Nº HF/mm
(Mean + SD)
DORSAL 
SKIN
Bayo, Table 1
GR+/- GR-/-GR+/+
E18.5
GL
SC
BL
SL
D FE
E16.5
BA C
E16.5
GR+/+
G
GR-/-
Bayo, Fig.1
Loricrin
Filaggrin
Involucrin
GR+/- GR-/-GR+/+
K6
Bayo, Fig.2
GR +/+ GR -/-
A
C
E
D
F
SC
GL
SL
BL
B
SC
GL
SL
BL
*
*
*
*
*
*
*
GR-/- GR+/+
G
16.5 dpc 18.5 dpcA
20 kda
30 kda
30 kda
45 kda
66 kda
97 kda
Procaspase-14
p20 fragment
Profilaggrin
Filaggrin
GR-/-GR+/+ GR-/-GR+/+
Actin
GR-/-GR+/+B
Caspase-14
Caspase-3
E
- Dex +/+ -/-
caspase-14A
caspase-14B
β-actin
MPKs 16.5 dpc
C
GR+/+
- Dex D
Procaspase-14
p20 fragment
Profilaggrin
Filaggrin
Actin
- Dex +/+ -/-
MPKs 16.5 dpc
20 kda
30 kda
30 kda
45 kda
66 kda
97 kda
Bayo, Fig.4
GGR-/-GR+/+% 
Br
dU
-
po
sit
ive
ke
ra
tin
oc
yt
e
s
0
10
20
30
40
50
*
GR-/-GR+/+
D
BrdU
K5
BA
C
F
GR+/+ GR+/--/-
E
%
Br
dU
-
po
sit
ive
ke
ra
tin
oc
yt
e
s
GR-/-GR+/+
0
5
10
15
20
Bayo, Fig.5
GR+/+ GR-/-
K10 INV INVK10
- 24h                   48h                   - 24h                  48hCa 2+
B
A
GR+/+
GR-/-
Ca2+ - 24h                 48hBayo, Fig.6
A GR+/+ GR-/-
p-ERK1
actin
JNK
p-JNK
p-ERK2
ERK1
ERK2
c-jun 
p-c-jun
GR
B
p-
ER
K/
ER
K
0
2
4
6
8
10
GR-/-GR+/+
*
GR-/-GR+/+
p-JNK
p-ERK
p-c-jun
C
Bayo, Fig.7
C0,0
1,0
2,0
3,0
4,0
5,0
6,0
7,0
p-
ER
K/
ER
K
GR-/-GR+/+
-PMA
+PMA
*
*
A
ERK
p-ERK
GR-/-GR+/+
p-ERK2
B
Actin
ERK2
GR +/+ GR -/-
PMA      - +       - +
ERK1
p-ERK1
vehicle
PD98059
TNF-α + CHX
Ap
op
to
si
s
(%
)
D
GR-/-GR+/+
0
5
10
15
20
25
30
35
40
*
*
*
GR+/+
Bayo, Fig.8
Loricrin
K5
K10
GR+/+ GRdim/dimB
A
GRdim/dim
GR+/+
GR-/-
Bayo, Fig.9
